NASDAQ:IRIX • US4626841013
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IRIDEX CORP (IRIX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-05-15 | Stifel | Maintains | Hold -> Hold |
| 2022-08-26 | Stifel | Downgrade | Buy -> Hold |
| 2021-05-12 | Roth Capital | Maintains | Buy |
| 2021-03-03 | Roth Capital | Maintains | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 56.97M 5.70% | 51.869M -8.95% | 48.669M -6.17% | 53.346M 9.61% | 57.68M 8.12% | 61.322M 6.31% | 64.88M 5.80% | |
| EBITDA YoY % growth | -7.05M -4.75% | -8.909M -26.37% | -7.718M 13.37% | 692.58K 108.97% | 1.953M 181.99% | 4.071M 108.45% | 5.166M 26.90% | |
| EBIT YoY % growth | -7.54M -0.13% | -10.007M -32.72% | -8.302M 17.04% | -4.998M 39.80% | -955.74K 80.88% | 1.174M 222.84% | 2.288M 94.89% | |
| Operating Margin | -13.24% | -19.29% | -17.06% | -9.37% | -1.66% | 1.91% | 3.53% | |
| EPS YoY % growth | -0.47 6.00% | -0.59 -25.53% | -0.54 8.47% | -0.28 49.00% | -0.07 74.07% | 0.05 171.43% | 0.10 100.00% |
All data in USD
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.02 59.20% | -0.05 49.00% |
| Revenue Q2Q % growth | 14.076M 10.83% | N/A |
| EBITDA Q2Q % growth | 102K 24.39% | N/A |
| EBIT Q2Q % growth | -408K 18.73% | N/A |
All data in USD
7 analysts have analysed IRIX and the average price target is 3.06 USD. This implies a price increase of 146.77% is expected in the next year compared to the current price of 1.24.
IRIDEX CORP (IRIX) will report earnings on 2026-05-11.
The consensus EPS estimate for the next earnings of IRIDEX CORP (IRIX) is -0.02 USD and the consensus revenue estimate is 14.08M USD.
The number of analysts covering IRIDEX CORP (IRIX) is 7.